Nutrigenomics: A Possible Road to Personalized Nutrition

Comprehensive Biotechnology, Second Edition

Volumn 4, Issue , 2011, Pages 703-712

  Cahill, L E ^a   El Sohemy, A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biomarkers; Genotype; Nutrigenetics; Nutrigenomics; Nutrition; Personalized nutrition; Polymorphism

Indexed keywords

EID: 85012819037     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-088504-9.00305-6     Document Type: Chapter

References (84)

1. Ordovas J.M. Genotype-phenotype associations: Modulation by diet and obesity. Obesity (Silver Spring) 2008, 16(supplement 3):S40-S46.
2. Ordovas J.M., Kaput J., Corella D. Nutrition in the genomics era: Cardiovascular disease risk and the Mediterranean diet. Molecular Nutrition Food Research 2007, 51:1293-1299.
3. El-Sohemy A. Nutrigenetics. Forum Nutrition 2007, 60:25-30.
4. Eny K.M., El-Sohemy A. The Genetic Determinants of Ingestive Behaviour: Sensory, Energy Homeostasis and Food Reward aspects of ingestive behaviour. Obesity Prevention: the role of brain and society on individual behavior 2010, 149-160. Elsevier. L. Dube, A. Bechara, A. Dagher, A. Drewnowski, J. LeBel, P. James, R.Y. Yada, M.-C. Laflamme-Sanders (Eds.).
5. Garcia-Bailo B., Toguri C., Eny K.M., El-Sohemy A. Genetic variation in taste and its influence on food selection. OMICS 2009, 13:69-80.
6. Swallow D.M. Genetics of lactase persistence and lactose intolerance. Annual Review of Genetics 2003, 37:197-219.
7. Swagerty D.L., Walling A.D., Klein R.M. Lactose intolerance. American Family Physician 2002, 65:1845-1850.
8. DiLella A.G., Kwok S.C., Ledley F.D., et al. Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene. Biochemistry 1986, 25:743-749.
9. Surtees R., Blau N. The neurochemistry of phenylketonuria. European Journal of Pediatrics 2000, 159(supplement 2):S109-S113.
10. Pediatrics 2000, 108:972-982.
11. Hines L.M., Stampfer M.J., Ma J., et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. New England Journal of Medicine 2001, 344:549-555.
12. Heidrich J., Wellmann J., Doring A., et al. Alcohol consumption, alcohol dehydrogenase and risk of coronary heart disease in the MONICA/KORA-Augsburg cohort 1994/1995-2002. European Journal of Cardiovascular Prevention and Rehabilitation 2007, 14:769-774.
13. Younis J., Cooper J.A., Miller G.J., et al. Genetic variation in alcohol dehydrogenase 1C and the beneficial effect of alcohol intake on coronary heart disease risk in the Second Northwick Park Heart Study. Atherosclerosis 2005, 180:225-232.
14. Djousse L., Levy D., Herbert A.G., et al. Influence of alcohol dehydrogenase 1C polymorphism on the alcohol-cardiovascular disease association (from the Framingham Offspring Study). American Journal of Cardiology 2005, 96:227-232.
15. Cornelis M.C., El-Sohemy A., Kabagambe E.K., Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. Journal of the American Medical Association 2006, 295:1135-1141.
16. Palatini P., Ceolotto G., Ragazzo F., et al. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. Journal of Hypertension 2009, 27:1594-1601.
17. Kotsopoulos J., Ghadirian P., El-Sohemy A., et al. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiology, Biomarkers and Prevention 2007, 16:912-916.
18. Nkondjock A., Ghadirian P., Kotsopoulos J., et al. Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. International Journal of Cancer 2006, 118:103-107.
19. Baker J.A., Beehler G.P., Sawant A.C., et al. Consumption of coffee, but not black tea, is associated with decreased risk of premenopausal breast cancer. Journal of Nutrition 2006, 136:166-171.
20. Wolfrom D.M., Rao A.R., Welsch C.W. Caffeine inhibits development of benign mammary gland tumors in carcinogen-treated female Sprague-Dawley rats. Breast Cancer Research and Treatment 1991, 19:269-275.
21. Yang H., Rouse J., Lukes L., et al. Caffeine suppresses metastasis in a transgenic mouse model: A prototype molecule for prophylaxis of metastasis. Clinical and Experimental Metastasis 2004, 21:719-735.
22. Corella D., Peloso G., Arnett D.K., et al. APOA2, dietary fat, and body mass index: Replication of a gene-diet interaction in 3 independent populations. Archives of Internal Medicine 2009, 169:1897-1906.
23. Helgadottir A., Manolescu A., Helgason A., et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nature Genetics 2006, 38:68-74.
24. Luan J., Browne P.O., Harding A.H., et al. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 2001, 50:686-689.
25. Barter P.J., Nicholls S., Rye K.A., et al. A ntiinflammatory properties of HDL. Circulation Research 2004, 95:764-772.
26. Chirovsky D.R., Fedirko V., Cui Y., et al. Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: A systematic review. European Journal of Cardiovascular Prevention and Rehabilitation 2009, 16:404-423.
27. Nesto R.W. Beyond low-density lipoprotein: Addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. American Journal of Cardiovascular Drugs 2005, 5:379-387.
28. Li T.Y., Zhang C., Asselbergs F.W., et al. Interaction between dietary fat intake and the cholesterol ester transfer protein TaqIB polymorphism in relation to HDL-cholesterol concentrations among US diabetic men. American Journal of Clinical Nutrition 2007, 86:1524-1529.
29. Ordovas J.M., Corella D., Demissie S., et al. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: Evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation 2002, 106:2315-2321.
30. Tai E.S., Corella D., Deurenberg-Yap M., et al. Dietary fat interacts with the -514C T polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: The 1998 Singapore National Health Survey. Journal of Nutrition 2003, 133:3399-3408.
31. Zhang C., Lopez-Ridaura R., Rimm E.B., et al. Interactions between the -514C T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men. American Journal of Clinical Nutrition 2005, 81:1429-1435.
32. Wijendran V., Hayes K.C. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annual Review of Nutrition 2004, 24:597-615.
33. Russo G.L. Dietary n-6 and n-3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention. Biochemical Pharmacology 2009, 77:937-946.
34. Ordovas J.M., Corella D., Cupples L.A., et al. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: The Framingham Study. American Journal of Clinical Nutrition 2002, 75:38-46.
35. Grimble R.F., Tappia P.S. Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids. Zeitschrift für Ernährungswissenschaft 1998, 37(supplement 1):57-65.
36. Popa C., van den Hoogen F.H., Radstake T.R., et al. Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis. Annals of the Rheumatic Diseases 2007, 66:1503-1507.
37. Svenungsson E., Gunnarsson I., Fei G.Z., et al. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis and Rheumatism 2003, 48:2533-2540.
38. Kaluza W., Reuss E., Grossmann S., et al. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. Journal of Investigative Dermatology 2000, 114:1180-1183.
39. Kroeger K.M., Carville K.S., Abraham L.J. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Molecular Immunology 1997, 34:391-399.
40. Fontaine-Bisson B., Wolever T.M., Chiasson J.L., et al. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. American Journal of Clinical Nutrition 2007, 86:768-774.
41. Fontaine-Bisson B., El-Sohemy A. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and plasma high-density lipoprotein-cholesterol concentrations in a population of young adults. Journal of Nutrigenetics and Nutrigenomics 2008, 1:215-223.
42. Fontaine-Bisson B., Wolever T.M., Connelly P.W., et al. NF-kappaB -94Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDL-cholesterol in two distinct populations. Atherosclerosis 2009, 204:465-470.
43. Plourde M., Vohl M.C., Vandal M., et al. Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men. British Journal of Nutrition 2009, 102:1121-1124.
44. Lindi V., Schwab U., Louheranta A., et al. Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. Molecular Genetics and Metabolism 2003, 79:52-60.
45. Caron-Dorval D., Paquet P., Paradis A.M., et al. Effect of the PPAR-alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids. Journal of Nutrigenetics and Nutrigenomics 2008, 1:205-212.
46. McCabe-Sellers B., Lovera D., Nuss H., et al. Personalizing nutrigenomics research through community based participatory research and omics technologies. OMICS 2008, 12:263-272.
47. Kaput J. Developing the promise of nutrigenomics through complete science and international collaborations. Forum of Nutrition 2007, 60:209-223.
48. Ferguson L.R. Nutrigenomics approaches to functional foods. Journal of the American Dietetic Association 2009, 109:452-458.
49. Kim M.K., Park J.H. Conference on "Multidisciplinary approaches to nutritional problems." Symposium on "Nutrition and health." Cruciferous vegetable intake and the risk of human cancer: Epidemiological evidence. Proceedings of the Nutrition Society 2009, 68:103-110.
50. He F.J., Nowson C.A., MacGregor G.A. Fruit and vegetable consumption and stroke: Meta-analysis of cohort studies. Lancet 2006, 367:320-326.
51. Lampe J.W. Interindividual differences in response to plant-based diets: Implications for cancer risk. American Journal of Clinical Nutrition 2009, 89:1553S-1557S.
52. Xu S., Wang Y., Roe B., Pearson W.R. Characterization of the human class mu glutathione-S-transferase gene cluster and the GSTM1 deletion. Journal of Biological Chemistry 1998, 273:3517-3527.
53. Bruhn C., Brockmoller J., Kerb R., et al. Concordance between enzyme activity and genotype of glutathione S-transferase theta (GSTT1). Biochemical Pharmacology 1998, 56:1189-1193.
54. Probst-Hensch N.M., Tannenbaum S.R., Chan K.K., et al. Absence of the glutathione S-transferase M1 gene increases cytochrome P4501A2 activity among frequent consumers of cruciferous vegetables in a Caucasian population. Cancer Epidemiology, Biomarkers and Prevention 1998, 7:635-638.
55. Lampe J.W., King I.B., Li S., et al. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: Changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis 2000, 21:1157-1162.
56. Lampe J.W., Chen C., Li S., et al. Modulation of human glutathione S-transferases by botanically defined vegetable diets. Cancer Epidemiology, Biomarkers and Prevention 2000, 9:787-793.
57. Behrens M., Meyerhof W. Bitter taste receptors and human bitter taste perception. Cellular and Molecular Life Sciences 2006, 63:1501-1509.
58. Bufe B., Breslin P.A., Kuhn C., et al. The molecular basis of individual differences in phenylthiocarbamide and propylthiouracil bitterness perception. Current Biology 2005, 15:322-327.
59. Mennella J.A., Pepino M.Y., Reed D.R. Genetic and environmental determinants of bitter perception and sweet preferences. Pediatrics 2005, 115:216-222.
60. El-Sohemy A., Stewart L., Khataan N., et al. Nutrigenomics of taste - impact on food preferences and food production. Forum of Nutrition 2007, 60:176-182.
61. Kim U.K., Jorgenson E., Coon H., et al. Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide. Science 2003, 299:1221-1225.
62. Wooding S., Kim U.K., Bamshad M.J., et al. Natural selection and molecular evolution in PTC, a bitter-taste receptor gene. American Journal of Human Genetics 2004, 74:637-646.
63. Drayna D. Human taste genetics. Annual Review of Genomics and Human Genetics 2005, 6:217-235.
64. Shiffman D., Ellis S.G., Rowland C.M., et al. Identification of four gene variants associated with myocardial infarction. American Journal of Human Genetics 2005, 77:596-605.
65. Fischer L.M., daCosta K.A., Kwock L., et al. Sex and menopausal status influence human dietary requirements for the nutrient choline. American Journal of Clinical Nutrition 2007, 85:1275-1285.
66. Kohlmeier M., da Costa K.A., Fischer L.M., Zeisel S.H. Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:16025-16030.
67. Boekholdt S.M., Meuwese M.C., Day N.E., et al. Plasma concentrations of ascorbic acid and C-reactive protein, and risk of future coronary artery disease, in apparently healthy men and women: The EPIC-Norfolk prospective population study. British Journal of Nutrition 2006, 96:516-522.
68. Jacob R.A., Sotoudeh G. Vitamin C function and status in chronic disease. Nutrition in Clinical Care 2002, 5:66-74.
69. Paolisso G., D'Amore A., Balbi V., et al. Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. American Journal of Physiology 1994, 266:E261-E268.
70. Sinclair A.J., Taylor P.B., Lunec J., et al. Low plasma ascorbate levels in patients with type 2 diabetes mellitus consuming adequate dietary vitamin C. Diabetic Medicine 1994, 11:893-898.
71. Loria C.M., Whelton P.K., Caulfield L.E., et al. Agreement among indicators of vitamin C status. American Journal of Epidemiology 1998, 147:587-596.
72. Levine M., Conry-Cantilena C., Wang Y., et al. Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:3704-3709.
73. Block G., Mangels A.R., Patterson B.H., et al. Body weight and prior depletion affect plasma ascorbate levels attained on identical vitamin C intake: A controlled-diet study. Journal of the American College of Nutrition 1999, 18:628-637.
74. Cahill L.E., Fontaine-Bisson B., El-Sohemy A. Functional genetic variants of glutathione S-transferase protect against serum ascorbic acid deficiency. American Journal of Clinical Nutrition 2009, 90:1411-1417.
75. Jiang R., Hu F.B., Giovannucci E.L., et al. Joint association of alcohol and folate intake with risk of major chronic disease in women. American Journal of Epidemiology 2003, 158:760-771.
76. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. Journal of the American Medical Association 1995, 274:1049-1057.
77. Blount B.C., Mack M.M., Wehr C.M., et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:3290-3295.
78. Bailey L.B. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C T polymorphism affect cancer risk: Intake recommendations. Journal of Nutrition 2003, 133:3748S-3753S.
79. Smith A.D., Kim Y.I., Refsum H. Is folic acid good for everyone?. American Journal of Clinical Nutrition 2008, 87:517-533.
80. Robitaille J., Hamner H.C., Cogswell M.E., Yang Q. Does the MTHFR 677C T variant affect the recommended dietary allowance for folate in the US population?. American Journal of Clinical Nutrition 2009, 89:1269-1273.
81. DeBusk R. Diet-related disease, nutritional genomics, and food and nutrition professionals. Journal of the American Dietetic Association 2009, 109:410-413.
82. Kaput J., Noble J., Hatipoglu B., et al. Application of nutrigenomic concepts to type 2 diabetes mellitus. Nutrition, Metabolism and Cardiovascular Diseases 2007, 17:89-103.
83. Office of Population Genomics, National Human Genome Research Institute, National Institutes of Health. A Catalog of Published Genome-Wide Association Studies.
84. Ding K., Kullo I.J. Genome-wide association studies for atherosclerotic vascular disease and its risk factors. Circulation: Cardiovascular Genetics 2009, 2:63-72.